24-norursodeoxycholic acid has been researched along with icg 001 in 1 studies
Studies (24-norursodeoxycholic acid) | Trials (24-norursodeoxycholic acid) | Recent Studies (post-2010) (24-norursodeoxycholic acid) | Studies (icg 001) | Trials (icg 001) | Recent Studies (post-2010) (icg 001) |
---|---|---|---|---|---|
35 | 2 | 27 | 108 | 1 | 102 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, HX; Liang, ZY; Qin, SY; Su, SB; Wang, F; Yan, YD; Zhangdi, HJ | 1 |
1 review(s) available for 24-norursodeoxycholic acid and icg 001
Article | Year |
---|---|
Crosstalk network among multiple inflammatory mediators in liver fibrosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hepatic Stellate Cells; Hepatocytes; Humans; Imidazoles; Inflammation; Inflammation Mediators; Liver; Liver Cirrhosis; Molecular Targeted Therapy; Protein Kinase Inhibitors; Pyrimidinones; Signal Transduction; Sulfoxides; Ursodeoxycholic Acid | 2019 |